Axxam SpA

BILLERICA, Mass. and MILAN, Nov. 16, 2023 /PRNewswire/ -- Axxam S.p.A. and Momentum Biotechnologies have announced a partnership to provide unique drug discovery solutions for biotechnology and pharmaceutical clients. Through the partnership Axxam's highly curated chemical diversity library, comprised of 325,000 compounds, will be available for high-throughput screening using Momentum's mass spectrometry-based functional and binding assay platforms. Primary hits may be progressed in hit-to-lead projects and additional downstream experiments including testing in cell-based assays. Continue Reading Axxam is a leader in providing early drug discovery services, offering a wide range of applications in addition to an extensive chemical diversity library. The Axxam library was built using decades of broad screening experience and significant input from medicinal and computational chemists. The library is composed of small molecules carefully selected for quality and structural diversity. Our clients will now have the option to access additional chemical matter for their drug discovery programs. Post this Momentum Biotechnologies is a bioanalytical contract research organization (CRO) specializing in early drug discovery and offers mass spectrometry-based high-throughput functional and binding assays. Founded by the team that originally commercialized the RapidFire™ high-throughput mass spectrometry platform, the company has decades of screening and hit characterization experience. "We are thrilled to enter this collaboration with Axxam" said Can Ozbal, CEO of Momentum. "Our clients will now have the option to access additional chemical matter for their drug discovery programs further enhancing our affinity selection mass spectrometry and functional assay services". Axxam CEO Stefan Lohmer added "with this collaboration Axxam clients will now have access to mass spectrometry-based HTS and hit-to-lead technologies expanding upon the wide range of services existing within the Axxam portfolio." About Axxam S.p.A. Axxam is an innovative Partner Research Organization (iPRO) providing integrated discovery services across the life sciences industries with headquarters located in Bresso (Milan, Italy). Within the drug discovery disciplines, Axxam supports pharma and biotech companies, start-ups, patient foundations as well as academic groups in their journey from target assessment and hit identification to lead generation, over all therapeutic areas and target classes. Axxam's services include assay development, high-throughput screening and hit-to-lead. The same science-driven approach is also applied to identify new bioactive compounds for crop protection, animal health, food, beverage, pet food, cosmetic and perfume industries. For more information, please visit About Momentum BiotechnologiesMomentum Biotechnologies is a specialized mass spectrometry services provider and discovery partner to biopharmaceutical clients globally. The Company's core team of scientists and engineers have been working together since 2000 when they built the RapidFire platform (sold to Agilent) and have been serving clients using RapidFire-MS since 2004. The team has been serving clients as PureHoney Technologies since 2015. Current services include affinity selection mass spectrometry-based ligand binding, irreversible covalent binding, functional and biomarker assays in addition to bioanalytical and proteomics services. For more information, please visit . SOURCE Momentum Biotechnologies

NEW YORK, Nov. 7, 2023 /PRNewswire/ -- The high throughput screening (HTS) market is expected to grow by USD 19.9 billion from 2023 to 2028. In addition, the market's momentum will progress at a CAGR of 12.12% during the forecast period, according to Technavio Research. The market has been segmented by Application (Target identification and validation, Primary and secondary screening, Toxicology assessment, and Stem cell research), End-user (Pharmaceutical and biotechnology companies, Academic and research institutes, and CROs), and Geography (North America, Europe, Asia, and Rest of World (ROW)). North America is estimated to contribute 40% to the growth of the global market during the forecast period. This growth is driven by the presence of key players that are constantly supporting an increasing number of pharmaceutical and biotechnology companies in this region through a diversified HTS portfolio, including BioRad Laboratories and Thermo Fisher Scientific. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read a Free PDF Sample Report Continue Reading Technavio has announced its latest market research report titled Global High Throughput Screening (HTS) Market 2024-2028 Company Profile: Agilent Technologies Inc., Aurora Biomed Inc., Axxam Spa, Beckman Coulter Inc., Bio Rad Laboratories Inc., Biomat Srl, BMG LABTECH GmbH, Charles River Laboratories International Inc., Corning Inc., Danaher Corp., DIANA Biotechnologies s.r.o, HighRes Biosolutions, JSR Life Sciences LLC, Lonza Group Ltd., Merck KGaA, NanoTemper Technologies GmbH, PerkinElmer Inc., Sygnature Discovery Ltd., Tecan Trading AG, and Thermo Fisher Scientific Inc. Agilent Technologies Inc. - The company offers high throughput screening products such as the Agilent RapidFire 400 high throughput mass spectrometry system. To access more company profiles available with Technavio, buy the report! High Throughput Screening (HTS) Market: Segmentation Analysis The market share growth by the target identification and validation segment will be significant during the forecast period. The growth of this segment will be enhanced by the progress made in identifying and validating new drug targets based on various approaches. Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report "Besides analyzing the current market scenario, our report examines historic data from 2017 to 2021"- Technavio High Throughput Screening (HTS) Market: Market Dynamics Rise in R and D investments Increasing prevalence of chronic diseases Patent expiration of drugs Key Driver The increasing prevalence of chronic diseases is the key factor driving market growth. HTS plays an important role in the discovery process, providing valuable information and saving time and money which is expected to help drive a market for highthroughput screening. Major Trend Increasing focus on promotional activities is the primary trend shaping market growth. Identify key trends, drivers, and challenges in the market. Download a sample to gain access to this information. Related Reports: The Life Sciences Analytics Market size is estimated to grow by USD 7,830.57 million at a CAGR of 12.02% between 2023 and 2028. The cell surface markers market size is estimated to grow by USD 14,068.95 million at a CAGR of 8.25% between 2023 and 2028. What are the key data covered in this high throughput screening (HTS) market report? CAGR of the market during the forecast period Detailed information on factors that will drive the growth of the high throughput screening (HTS) market between 2023 and 2028. Precise estimation of the high throughput screening (HTS) market size and its contribution to the market in focus on the parent market Accurate predictions about upcoming trends and changes in consumer behavior Growth of the high throughput screening (HTS) market across North America, Europe, Asia, and ROW A thorough analysis of the market's competitive landscape and detailed information about companies Comprehensive analysis of factors that will challenge the growth of high throughput screening (HTS) market companies. ToC: Executive Summary Market Landscape Market Sizing Historic Market Sizes Five Forces Analysis Market Segmentation by Application Market Segmentation by End-User Market Segmentation by Geography Customer Landscape Geographic Landscape Drivers, Challenges, & Trends Company Landscape Company Analysis Appendix About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contacts Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: [email protected] Website: SOURCE Technavio

DUBLIN--( BUSINESS WIRE )--The "Global High Throughput Process Development Market (2022-2027) by Product & Service, Molecule Type, Technology, End User, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering. The Global High Throughput Process Development Market is estimated to be USD 502.2 Mn in 2022 and is expected to reach USD 1013.62 Mn by 2027, growing at a CAGR of 15.08% Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding growth and reducing risks. Countries Studied America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas) Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe) Middle East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA) Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific) Competitive Quadrant The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc. Ansoff Analysis The report presents a detailed Ansoff matrix analysis for the Global High Throughput Process Development Market. Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach. The analyst analyses the Global High Throughput Process Development Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth. Why buy this report? The report offers a comprehensive evaluation of the Global High Throughput Process Development Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies. The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry. The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report. The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies. The report also contains a competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool. Market Dynamics Drivers Technological Advancements in Process Development Growing Pressure to Lower the Cost of Manufacturing Restraints Lack of Adequate Infrastructural Facilities Opportunities Increase in Research and Development Growth in the Biopharmaceutical Industry Challenges Lack of Skilled Professional Market Segmentation The Global High Throughput Process Development Market is segmented based on Product & Service, Molecule Type, Technology, End User, and Geography. By Product & Service, the market is classified into Software, Instruments, Services and Software. By Molecule Type, the market is classified into Monoclonal Antibodies and Other Molecules. By Technology, the market is classified into Chromatography and Ultraviolet-Visible Spectroscopy. By End User, the market is classified into Biopharmaceutical, Contract Research Organization and Academic Research Institutes. By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific. Companies Mentioned Agilent Technologies, Inc. Aurora Biomed Inc. AXXAM S.p.A. Beckman Coulter, Inc. Biomat S.r.l Bio-Rad Laboratories, Inc. Biotek Instruments Inc. BMG Labtech Charles River Laboratories Corning Inc. Danaher Corp. Eppendorf Eurofins Scientific F. Hoffmann-La Roche Ag GE Healthcare Hamilton Company Luminex Corp. Merck Millipore Molecular Devices, LLC. PerkinElmer, Inc. Promega Corp. Reprocell, Inc. Sartorius Stedim Biotech Tecan Group, Ltd. Thermo Fisher Scientific Inc. For more information about this report visit https://www.researchandmarkets.com/r/sfrwcs